Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedAdded a MedlinePlus Genetics topic for Multiple myeloma, expanding core content. The page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed as a minor UI cleanup.SummaryDifference0.7%
- Check12 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of multiple myeloma has been removed from the MedlinePlus Genetics section.SummaryDifference0.7%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as a range of scientific terms related to proteins and diseases, while removing several previous terms related to immunological agents and multiple myeloma.SummaryDifference7%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.